News Releases

September 1, 2017

Indivior Responds To Court Rulings in ANDA Litigation and Announces Intention To Appeal

August 22, 2017

Indivior Opens $30 Million Research and Development Center to Advance Treatment Innovation

July 31, 2017

Indivior’s NALSCUE® Receives Marketing Authorization from French Regulatory Agency ANSM

July 31, 2017

Indivior RBP-6000 NDA Acceptance with Priority Review Designation

July 27, 2017

Indivior H1 2017 Financial Results

July 13, 2017

Indivior to Announce Half Year 2017 Results on July 27th

June 29, 2017

Reminder RBP-6000 Investor Event Announcement

June 21, 2017

RBP-6000 Data Presented in Late-Breaking Research Oral Session at CPDD 79th Annual Scientific Meeting

June 16, 2017

RBP-6000 Investor Event Announcement

June 6, 2017

Webcast Event: Shaun Thaxter, CEO of Indivior PLC presented at the Jefferies Global Healthcare Conference on June 6, 2017